Momelotinib Yields Clinically Significant Improvement in Myelofibrosis
MONDAY, Feb. 6, 2023 (HealthDay News) — Treatment with momelotinib versus danazol yields clinically significant improvements for patients with myelofibrosis, according to a study published online Jan. 28 in The Lancet.Srdan Verstovsek, M.D., from the…
Learn MoreASTRO: Ultra-High-Dose Radiotherapy Feasible for Extremity Bone Mets
FRIDAY, Oct. 28, 2022 (HealthDay News) — Ultra-high-dose-rate radiotherapy delivered at more than 40 Gy/sec (FLASH therapy) is clinically feasible for extremity bone metastases, according to a study published online Oct. 23 in JAMA Oncology to coinci…
Learn More